Cargando…
Identification of variants and therapeutic epitopes in HPV-33/HPV-58 E6 and E7 in Southwest China
BACKGROUND: Human papillomavirus (HPV) E6 and E7 oncoproteins play a crucial role in HPV-related diseases, such as cervical cancer, and can be used as ideal targets for therapeutic vaccines. Human leukocyte antigen (HLA) participates in the immune response to block HPV infection and invasion by its...
Autores principales: | He, Jiaoyu, Yang, Yasi, Chen, Zuyi, Liu, Yang, Bao, Shanfei, Zhao, Yun, Ding, Xianping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537359/ https://www.ncbi.nlm.nih.gov/pubmed/31138240 http://dx.doi.org/10.1186/s12985-019-1168-y |
Ejemplares similares
-
E6 and E7 Gene Polymorphisms in Human Papillomavirus Types-58 and 33 Identified in Southwest China
por: Chen, Zuyi, et al.
Publicado: (2017) -
Correction: E6 and E7 Gene Polymorphisms in Human Papillomavirus Types-58 and 33 Identified in Southwest China
por: Chen, Zuyi, et al.
Publicado: (2017) -
L1 and L2 gene polymorphisms in HPV-58 and HPV-33: implications for vaccine design and diagnosis
por: Chen, Zuyi, et al.
Publicado: (2016) -
The polymorphisms of LCR, E6, and E7 of HPV-58 isolates in Yunnan, Southwest China
por: Xi, Juemin, et al.
Publicado: (2018) -
Phylogeny and polymorphism in the long control regions E6, E7, and L1 of HPV Type 56 in women from southwest China
por: Jing, Yaling, et al.
Publicado: (2018)